123 related articles for article (PubMed ID: 25989631)
21. Using mass spectrometry to monitor monoclonal immunoglobulins in patients with a monoclonal gammopathy.
Barnidge DR; Dasari S; Botz CM; Murray DH; Snyder MR; Katzmann JA; Dispenzieri A; Murray DL
J Proteome Res; 2014 Mar; 13(3):1419-27. PubMed ID: 24467232
[TBL] [Abstract][Full Text] [Related]
22. Involved/uninvolved heavy/light chain index can predict progression in transplanted multiple myeloma patients.
Espiño M; Arteche-López A; Medina S; Muñoz-Calleja C; Blanchard MJ; Alegre A; López-Jiménez FJ; Villar LM
Bone Marrow Transplant; 2017 Aug; 52(8):1206-1207. PubMed ID: 28581457
[No Abstract] [Full Text] [Related]
23. The potential of serum light chains in diffuse large B-cell lymphoma.
Maurer MJ
Leuk Lymphoma; 2013 Sep; 54(9):1857-8. PubMed ID: 23517591
[No Abstract] [Full Text] [Related]
24. Screening panels for detection of monoclonal gammopathies: confidence intervals.
Pretorius CJ; Ungerer JP; Wilgen U; Klingberg S
Clin Chem; 2010 Apr; 56(4):677-9; author reply 679-80. PubMed ID: 20110450
[No Abstract] [Full Text] [Related]
25. [Determination of light chains in serum].
Hansen CT; Nielsen L; Münster AM; Abildgaard N
Ugeskr Laeger; 2010 Aug; 172(34):2302-5. PubMed ID: 20727297
[TBL] [Abstract][Full Text] [Related]
26. Heavy/light chain assay for monitoring IgA multiple myeloma: digging out the IgA from the β region.
Calderon B
Clin Chem; 2015 Feb; 61(2):317-8. PubMed ID: 25501934
[No Abstract] [Full Text] [Related]
27. Comparison of Hevylite™ IgA and IgG assay with conventional techniques for the diagnosis and follow-up of plasma cell dyscrasia.
Paolini L; Di Noto G; Maffina F; Martellosio G; Radeghieri A; Luigi C; Ricotta D
Ann Clin Biochem; 2015 May; 52(Pt 3):337-45. PubMed ID: 25468997
[TBL] [Abstract][Full Text] [Related]
28. Analysis of patients with γ-heavy chain disease by the heavy/light chain and free light chain assays.
Kaleta E; Kyle R; Clark R; Katzmann J
Clin Chem Lab Med; 2014 May; 52(5):665-9. PubMed ID: 24327529
[TBL] [Abstract][Full Text] [Related]
29. Classification of Plasma Cell Disorders by 21 Tesla Fourier Transform Ion Cyclotron Resonance Top-Down and Middle-Down MS/MS Analysis of Monoclonal Immunoglobulin Light Chains in Human Serum.
He L; Anderson LC; Barnidge DR; Murray DL; Dasari S; Dispenzieri A; Hendrickson CL; Marshall AG
Anal Chem; 2019 Mar; 91(5):3263-3269. PubMed ID: 30801187
[TBL] [Abstract][Full Text] [Related]
30. Patients assigned to VGPR, PR, and SD in the IMWG response category are composed of heterogeneous population when assessed by the heavy/light chain assay.
Kamiya Y; Chou T; Murakami H; Handa H; Ozaki S; Shimazaki C; Fuchida SI; Okada J; Itoh J; Sugiyama S; Shimizu K
Hematol Oncol; 2019 Aug; 37(3):316-318. PubMed ID: 30938836
[No Abstract] [Full Text] [Related]
31. Immunoparesis in IgM gammopathies as a useful biomarker to predict disease progression.
Andrade-Campos M; Murillo-Flórez I; García-Sanz R; Giraldo P
Clin Chem Lab Med; 2017 Aug; 55(10):1598-1604. PubMed ID: 28284031
[TBL] [Abstract][Full Text] [Related]
32. [Detection of free light chains--a new method of diagnostics of haematological diseases].
Mecl J; Benáková H; Nohejlová A; Straub J; Zima T; Spicka I
Cas Lek Cesk; 2007; 146(2):159-62. PubMed ID: 17373113
[TBL] [Abstract][Full Text] [Related]
33. [New insights into monoclonal gammopathy and multiple myeloma].
Grosbois B
Rev Med Interne; 2007 Oct; 28(10):667-9. PubMed ID: 17553600
[No Abstract] [Full Text] [Related]
34. Serum free light chain assays: detecting plasma cell disorders.
Rogoski RR
MLO Med Lab Obs; 2009 Jul; 41(7):10, 12-6; quiz 20-1. PubMed ID: 19685691
[No Abstract] [Full Text] [Related]
35. Commentary.
Bennett ST
Clin Chem; 2010 Sep; 56(9):1393. PubMed ID: 20802100
[No Abstract] [Full Text] [Related]
36. Detecting monoclonal immunoglobulins in human serum using mass spectrometry.
Mills JR; Barnidge DR; Murray DL
Methods; 2015 Jun; 81():56-65. PubMed ID: 25916620
[TBL] [Abstract][Full Text] [Related]
37. Heavy and light chains all at once: A new immunofluorescence technique to evaluate monoclonal immunoglobulin deposits.
Santoriello D; Markowitz GS
Kidney Int; 2021 Jul; 100(1):22-24. PubMed ID: 34154710
[TBL] [Abstract][Full Text] [Related]
38. The immunoglobulin isotype matters in diffuse-large-B-cell lymphoma with serum paraproteinaemia.
Cox MC; Di Napoli A; Scarpino S; Ruco L
Ann Hematol; 2015 Apr; 94(4):681-2. PubMed ID: 25193355
[No Abstract] [Full Text] [Related]
39. Immunoparesis defined by heavy+light chain suppression is a novel marker of long-term outcomes in cardiac AL amyloidosis.
Sachchithanantham S; Berlanga O; Alvi A; Mahmood SA; Lachmann HJ; Gillmore JD; Hawkins PN; Harding S; Wechalekar AD
Br J Haematol; 2017 Nov; 179(4):575-585. PubMed ID: 28990174
[TBL] [Abstract][Full Text] [Related]
40. Protein electrophoresis and serum free light chains in the diagnosis and monitoring of plasma cell disorders: laboratory testing and current controversies.
Tate JR; Graziani MS; Mollee P; Merlini G
Clin Chem Lab Med; 2016 Jun; 54(6):899-905. PubMed ID: 27107838
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
